Position in DYAI
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$293,580
+$26,096 QoQ
Shares Held
326,200
0.0% QoQ
Ownership
0.895%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 39 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DYAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $119,351,579 across 51 Biotechnology names. DYAI ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,967 | $53,133,716 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,731 | $24,150,326 | |
| 3 | ARGX |
Argenx SE
|
3,790 | $3,516,247 | |
| 4 | EXEL |
Exelixis, Inc.
|
63,541 | $3,457,265 | |
| 5 | URGN |
UroGen Pharma Ltd.
|
72,286 | $2,660,124 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,121 | $2,438,856 | |
| 7 | VCEL |
Vericel Corp
|
51,315 | $2,283,003 | |
| 8 | RPRX |
Royalty Pharma plc
|
29,890 | $1,675,931 |
All Filings in DYAI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $293,580 | 326,200 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $267,484 | 326,200 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $306,628 | 326,200 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $384,916 | 326,200 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $247,500 | 250,000 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $337,500 | 250,000 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $437,500 | 250,000 | Shares | Defined | 2025-01-31 | |
| No filing history on record for this holder in this stock. | ||||||